Advertisement

Chlamydia pneumoniae:A New Possible Cause of Asthma

  • D. L. Hahn
  • L. Allegra

Abstract

Asthma is a chronic respiratory condition of uncertain etiology and often multifactorial that is characterized by chronic bronchial inflammation and airway hyperreactivity that result in episodes of reversible airway obstruction usually manifested as symptoms of cough, shortness of breath and wheeze triggered by a variety of stimuli [1]. Earlier in this century it was generally believed that focal infections were one cause of asthma [2]. Nowadays most experts believe that asthma is exclusively a noninfectious inflammatory lung condition, although a role for viral infections as triggers of asthma exacerbations is widely acknowledged [1]. The current belief in an exclusively noninfectious cause for asthma is based in part on the lack of effectiveness, in producing longlasting asthma remissions, of antibiotic treatment of conventional respiratory pathogens. Recent evidence suggests a causal role for the atypical respiratory pathogen, Chlamydia pneumoniae, in the initiation, exacerbation and promotion of asthma [3]. Eradication of this organism from the respiratory tract is difficult and often requires longer than conventional courses of specific antichlamydial antibiotics. It is not likely that antibiotic treatment directed against traditional pyogenic bacteria would eradicate C. pneumoniae.

Keywords

Acute Respiratory Illness Geometric Mean Titer Reactive Airway Disease Asthmatic Bronchitis Strain TWAR 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Anonimous (1997) Expert Panel Report II. Guidelines for the diagnosis and management of asthma. US Department of Health and Human Services, Public Health Service. National Institutes of Health, National Heart, Lung, and Blood Institute, FebruaryGoogle Scholar
  2. 2.
    Thomas WS (1928) Asthma: its diagnosis and treatment. Hoeber, New YorkGoogle Scholar
  3. 3.
    Hahn DL (1996) Intracellular pathogens and their role in asthma: Chlamydia pneumoniae in adult patients. Eur Respir Rev 6: 224–230Google Scholar
  4. 4.
    The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee (1998) Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 351: 1225–1232CrossRefGoogle Scholar
  5. 5.
    Burr ML (1987) Is asthma increasing? J Epidemiol Comm Health 41: 185–189CrossRefGoogle Scholar
  6. 6.
    Lewis S (1998) ISAAC-a hypothesis generator for asthma? Lancet 351: 1220–1221PubMedCrossRefGoogle Scholar
  7. 7.
    Hahn DL (1995) Infectious asthma: a reemerging clinical entity? J Fam Pract 41: 153–157PubMedGoogle Scholar
  8. 8.
    Smith JM (1994) Asthma and atopy as diseases of unknown cause. A viral hypothesis possibly explaining the epidemiologic association of the atopic diseases and various forms of asthma. Ann Allergy 72: 156–162PubMedGoogle Scholar
  9. 9.
    Grayston JT (1992) Infections caused by Chlamydia pneumoniae strain TWAR. Clin Infect Dis 15: 757–763PubMedCrossRefGoogle Scholar
  10. 10.
    Hammerschlag MR, Chirgwin K, Roblin PM et al (1992) Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis 14: 178–182PubMedCrossRefGoogle Scholar
  11. 11.
    Falck G, Engstrand I, Gad A et al (1997) Demonstration of Chlamydia pneumoniae in patients with chronic pharyngitis. Scand J Infect Dis 29: 585–589PubMedCrossRefGoogle Scholar
  12. 12.
    Falck G, Gnarpe J, Gnarpe H (1997) Persistent Chlamydia pneumoniae infection in a Swedish family. Scand J Infect Dis 28: 271–273CrossRefGoogle Scholar
  13. 13.
    Normann E, Gnarpe J, Gnarpe H et al (1998) Chlamydia pneumoniae in children attending day-care-centers in Gävle, Sweden. Pediatr Infect Dis J 17: 474–478PubMedCrossRefGoogle Scholar
  14. 14.
    Boman J, Söderberg S, Forsberg J et al (1998) High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. J Infect Dis 178: 274–277PubMedCrossRefGoogle Scholar
  15. 15.
    Grayston JT, Kuo C-C, Wang S-P et al (1986) A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. New Engl J Med 315: 161–168PubMedCrossRefGoogle Scholar
  16. 16.
    Frydén A, Kihlström E, Maller R et al (1989) A clinical and epidemiological study of “ornithosis” caused by Chlamydia psittaci and Chlamydia pneumoniae (strain TWAR). Scand J Infect Dis 21: 681–691PubMedCrossRefGoogle Scholar
  17. 17.
    Kawane H (1993) Chlamydia pneumoniae. Thorax 48: 871PubMedCrossRefGoogle Scholar
  18. 18.
    Hahn DL (1994) Infection as a cause of asthma. Ann Allergy 73: 276PubMedGoogle Scholar
  19. 19.
    Thom DH, Grayston JT, Campbell LA et al (1994) Respiratory infection with Chlamydia pneumoniae in middle-aged and older adult outpatients. Eur J Clin Microbiol Infect Dis 13: 785–792PubMedCrossRefGoogle Scholar
  20. 20.
    Thom D (1994) Lower respiratory tract infection with Chlamydia pneumoniae. Arch Fam Med 3: 828–832PubMedCrossRefGoogle Scholar
  21. 21.
    Aldous MB, West S, Kimaro DN et al (1996) Chlamydia pneumoniae (TWAR) infection in Tanzanian children. Trop Doct 26: 18–19PubMedGoogle Scholar
  22. 22.
    Korppi M, Leinonen M, Koskela M et al (1991) Bacterial infection in under school age children with expiratory difficulty. Pediatr Pulmonol 10: 254–259PubMedCrossRefGoogle Scholar
  23. 23.
    Korppi M, Leinonen M, Saikku P (1995) Chlamydial infection and reactive airway disease. Arch Pediatr Adolesc Med 149: 341–342PubMedCrossRefGoogle Scholar
  24. 24.
    Emre U, Roblin PM, Gelling M et al (1994) The association of Chlamydia pneumoniaeinfection and reactive airway disease in children. Arch Pediatr Adolesc Med 148: 727–732PubMedCrossRefGoogle Scholar
  25. 25.
    Cunningham A, Johnston S, Julious S et al (1994) The role of Chlamydia pneumoniaeand other pathogens in acute episodes of asthma in children. In: Orfila J, Byrne GI, Chernesky MA et al (eds) Proceedings of the 8th International Symposium on Human Chlamydial Infections, Chantilly, France. Esculapio, Bologna, pp 480–483Google Scholar
  26. 26.
    Johnston SL (1997) Influence of viral and bacterial respiratory infections on exacerbations and symptom severity in childhood asthma. Pediatr Pulmonol 16: 88–89Google Scholar
  27. 27.
    Prückl PM, Aspöck C, Makristathis A et al (1995) Polymerase chain reaction for detection of Chlamydia pneumoniae in gargled-water specimens of children. Eur J Clin Microbiol Infect Dis 14: 141–144PubMedCrossRefGoogle Scholar
  28. 28.
    Gnarpe J, Gnarpe H, Normann E et al (1996) Chlamydia pneumoniae, Mycoplasma pneumoniae and Mycoplasma fermentons PCR in children with acute respiratory tract infections (abstract C-160). In: Abstracts of the 96th General Meeting of the American Society for Microbiology, New Orleans, LA, 19–23 May, 1996, p 29Google Scholar
  29. 29.
    Hahn DL, Dodge R, Golubjatnikov R (1991) Association of Chlamydia pneumoniae(strain TWAR) infection with wheezing, asthmatic bronchitis and adult-onset asthma. JAMA 266: 225–230PubMedCrossRefGoogle Scholar
  30. 30.
    Hahn DL, Golubjatnikov R (1994) Asthma and chlamydial infection: a case series. J Fam Pract 38: 589–595PubMedGoogle Scholar
  31. 31.
    Allegra L, Blasi F, Centanni S et al (1994) Acute exacerbations of asthma in adults: role of Chlamydia pneumoniae infection. Eur Respir J 7: 2165–2168PubMedCrossRefGoogle Scholar
  32. 32.
    Resta O, Monno R, Saracino A et al (1995) Chlamydia pneumonae infection in Italian patients. Monaldi Arch Chest Dis 50: 173–176PubMedGoogle Scholar
  33. 33.
    Hahn DL (1995) Treatment of Chlamydia pneumoniae infection in adult asthma: a before-after trial. J Fam Pract 41: 345–351PubMedGoogle Scholar
  34. 34.
    Hahn D (1996) Incident wheezing and prevalent asthma have different serologic patterns of “acute” Chlamydia pneumoniae antibodies in adults. In: Proceedings of the 3rd Meeting of the European Society for Chlamydia Research, Vienna, Austria. Esculapio, Bologna, p 226Google Scholar
  35. 35.
    Peeling RW, Hahn D, Dillon E (1996) Chlamydia pneumoniae infection and adult-onset asthma. In: Proceedings of the 3rd Meeting of the European Society for Chlamydia Research, Vienna, Austria. Esculapio, Bologna, p 228 (abstract)Google Scholar
  36. 36.
    Hahn D, Bukstein D, Luskin A et al (1998) Evidence for Chlamydia pneumoniae infection in steroid-dependent asthma. Ann Allergy Asthma Immunol 80: 45–49PubMedCrossRefGoogle Scholar
  37. 37.
    Peters BS, Thomas B, Marshall B et al (1994) The role of Chlamydia pneumoniae in acute exacerbations of asthma (part 2 of 2). Am J Respir Crit Care Med 149: A341Google Scholar
  38. 38.
    Weiss S, Quist J, Roblin P et al (1995) The relationship between Chlamydia pneumoniae and bronchospasm in adults (abstract K39). In: Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, California. American Society for Microbiology, p 294Google Scholar
  39. 39.
    Emre U, Sokolovskaya N, Roblin P et al (1995) Detection of Chlamydia pneumoniae-IgE in children with reactive airway disease. J Infect Dis 172: 265–267PubMedCrossRefGoogle Scholar
  40. 40.
    Emre U, Bernius M, Roblin P et al (1996) Chlamydia pneumoniae infection in patients with cystic fibrosis. Clin Infect Dis 22: 819–823PubMedCrossRefGoogle Scholar
  41. 41.
    Hahn DL, Anttila T, Saikku P (1996) Association of Chlamydia pneumoniae IgA antibodies with recently symptomatic asthma. Epidemiol Infect 117: 513–517PubMedCrossRefGoogle Scholar
  42. 42.
    Hahn DL, McDonald RA (1996) Association of serum IgA antibody against Chlamydia pneumoniae with “infectious” asthma (Abstract C-152). 96th General Meeting of the American Society for Microbiology, New Orleans, LA, 19–23 May, 1996, p 29Google Scholar
  43. 43.
    Björnsson E, Helm E, Janson C et al (1996) Serology of Chlamydia in relation to asthma and bronchial hyperresponsiveness. Scand J Infect Dis 28: 63–69PubMedCrossRefGoogle Scholar
  44. 44.
    Brüggen H, Kaspar P, Petro W (1996) Significance of TWAR-antigen immunofluorescence test and serologic Chlamydia anti-rLPS antibody test results compared with clinical findings in asthmatic patients. In: Proceedings of the 3rd Meeting of the European Society for Chlamydia Research, Vienna, Austria. Esculapio, Bologna, p 227Google Scholar
  45. 45.
    Cook PJ, Davies P, Tunnicliffe W et al (1998) Chlamydia pneumoniae and asthma. Thorax 53: 254–259PubMedCrossRefGoogle Scholar
  46. 46.
    von Hertzen L, Töyrlä M, Gimishanov A et al (1998) Asthma, atopy and Chlamydia pneumoniae antibodies in adults. In: Stephens RS, Byrne GI, Christiansen G et al (eds) Proceedings of the 9th International Symposium on Human Chlamydial Infection, Napa, CA, ISBN 0-9664383-0-2, pp 171-174Google Scholar
  47. 47.
    Miyashita N, Kubota Y, Nakajima M et al (1998) Chlamydia pneumoniae and exacerbations of asthma in adults. Ann Allergy Asthma Immunol 80: 405–409PubMedCrossRefGoogle Scholar
  48. 48.
    Hahn DL, Golubjatnikov R (1994) Age at asthma diagnosis, skin test positivity and Chlamydia pneumoniae seroreactivity (part 2 of 2). Am J Respir Crit Care Med 149: A913 (abstract)Google Scholar
  49. 49.
    Grayston JT, Golubjatnikov R, Hagiwara T et al (1993) Serologic tests for Chlamydia pneumoniae. Pediatr Infect Dis J 12: 790–791PubMedGoogle Scholar
  50. 50.
    Jenkins C, Blasi F, Allegra L, Black P, Hopkins S (1998) Chlamydia pneumoniae Asthma Roxithromycin Multinational Study (CARM): seroprevalence results. 4th International Conference on the macrolides, azalides, streptogamins and ketolides, Barcelona, 21–23 January, 1998, p 5Google Scholar

Copyright information

© Springer-Verlag Italia, Milano 1999

Authors and Affiliations

  • D. L. Hahn
  • L. Allegra

There are no affiliations available

Personalised recommendations